Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily N Truckenbrod

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|May 27, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob H Hullsiek, Kate J Dixon, et al.
Elife|April 30, 2021
CD8<sup>+</sup> T cell self-tolerance permits responsiveness but limits tissue damageEmily N Truckenbrod, Kristina S Burrack, Todd P Knutson, et al.
Journal for Immunotherapy of Cancer|July 25, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob Hullsiek, Kate J Dixon, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|May 27, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob H Hullsiek, Kate J Dixon, et al.
Elife|April 30, 2021
CD8<sup>+</sup> T cell self-tolerance permits responsiveness but limits tissue damageEmily N Truckenbrod, Kristina S Burrack, Todd P Knutson, et al.
Journal for Immunotherapy of Cancer|July 25, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsAnders W Matson, Rob Hullsiek, Kate J Dixon, et al.
Pageof 1